Economic impact of industry-sponsored clinical trials of pharmaceutical products in Austria.
Conclusions: In conclusion, conducting clinical-trials by pharmaceutical industry - beside its importance in its own domain - results in tangible benefits and positive macroeconomic impact that contribute to the sustainability of the Austrian health-care-system by complementing its limited resources. Furthermore, it is a non-negligible factor in locational and industrial policy.
PMID: 32046538 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Austria Health | Clinical Trials | Economics | Economy | Employment | Health Management | Jobs | Study